Home » Case Studies » Optimizing Pre-Launch Medical Affairs Engagement
Optimizing Pre-Launch Medical Affairs Engagement
SITUATION AND CHALLENGES
Client is entering a very competitive rare disease market with limited established relationships and a small field medical team

- Client aims to:
- Identify relevant HCPs with potential patients to either become clinical trialists or refer patients to current clinical trialists
- Map influential HCPs within the target rare disease space

Patient diagnosis and treatment journey include multiple HCP specialties, further complicating clinical trial recruiting and HCP targeting

Given competitive dynamics, the longer-term objective is to build trusted relationships for medical education, collaboration, and future
engagement planning
OUR APPROACH
- 81qd leveraged a 2-phased approach to identify and prioritize the appropriate HCPs both for clinical trials and for educational efforts, as well as aligning those HCPs to a curated field team to optimize engagement strategy
- Phase 1: Clinical Trial Recruitment Analysis
- Defined appropriate patients for clinical trials and mapped them to relevant treating and referring clinicians
- Prioritized clinicians based on proximity to clinical trial site and treatment patterns
- Clinician information was provided for outreach on potential interest for clinical trial involvement
- Phase 2: Influencer Identification
- Academic Leader Identification
- Programmatic mining of relevant publicly available data, such as publications, conferences, guidelines, etc
- Data analyzed and insights extracted to finalize a list of influential national leaders with scholarly activity
- Clinical Leader Identification
- A proprietary network analytics model analyzed patient-level data to find regional/local clinician influencers
OUTPUTS
Clinical Trial Recruitment Analysis

2K+ viable HCPs with potential patients for the clinical trial were uncovered, including HCPs who would not have been part of traditional trialrecruitment efforts
Academic Leader Identification

280+ Academic Leaders identified for engagements related to disease education
Clinical Leader Identification

390+ Clinical Leaders delivered, informing treatment patterns and network influence
This approach resulted in a strong foundation to support accelerated trial progress and cultivation of new relationships